Daria V Lizneva, MD, PhD

img_Daria V Lizneva
ASSOCIATE PROFESSOR | Pharmacological Sciences
Publications

Selected Publications

Corrigendum to “From discovery to therapeutic development of monoclonal antibodies” [J. Control. Release., Volume 396, 10 August 2026, Article 115034]. Satish Rojekar, Amol D. Gholap, Anusha R. Pallapati, Rauf Latif, Pavimol Angsantikul, Nagavendra Kommineni, Farhath Sultana, Anne Macdonald, Darya Vasilyeva, Steven Sims, Surabhi Parte, Clement Haeck, Rukmani Pandey, Judit Gimenez-Roig, Anisa Gumerova, Uliana Cheliadinova, Georgii Pevnev, Guzel Burganova, Zehra Tumoglu, Maryam Mansoori, Wei Yi, Orly Barak, Susan Hutchison, Francisco Fueyo González, Ki A. Goosens, Weibin Zhou, Vitaly Ryu, Ofer Moldavski, Tal Frolinger, Se Min Kim, Daria Lizneva, Tony Yuen, Mone Zaidi. Journal of Controlled Release

From discovery to therapeutic development of monoclonal antibodies. Satish Rojekar, Amol D. Gholap, Anusha R. Pallapati, Rauf Latif, Pavimol Angsantikul, Nagavendra Kommineni, Farhath Sultana, Anne Macdonald, Darya Vasilyeva, Steven Sims, Surabhi Parte, Clement Haeck, Rukmani Pandey, Judit Gimenez-Roig, Anisa Gumerova, Uliana Cheliadinova, Georgii Pevnev, Guzel Burganova, Zehra Tumoglu, Maryam Mansoori, Wei Yi, Orly Barak, Susan Hutchison, Francisco Fueyo González, Ki A.Goosens, Weibin Zhou, Vitaly Ryu, Ofer Moldavski, Tal Frolinger, Se Min Kim, Daria Lizneva, Tony Yuen, Mone Zaidi. Journal of Controlled Release

Fshr gene depletion prevents recognition memory loss, fat accrual and bone loss in Alzheimer’s mice. Uliana Cheliadinova, Steven Sims, Funda Korkmaz, Darya Vasilyeva, Victoria Laurencin, Judit Gimenez-Roig, Georgii Pevnev, Guzel Burganova, Zehra Tumoglu, Surabhi Parte, Farhath Sultana, Anusha R. Pallapati, Satish Rojekar, Anne Macdonald, Susan Hutchison, Avi Soussan, Anchine Liu, Yi Wei, Ofer Moldavski, Anisa Gumerova, Weibin Zhou, Orly Barak, Ki A. Goosens, Vitaly Ryu, Daria Lizneva, Clifford J. Rosen, Tony Yuen, Tal Frolinger, Mone Zaidi. Molecular Psychiatry

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Lizneva has not yet completed reporting of industry relationships or has no industry relationships to report.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.